Peregrine Asset Advisers’s CytomX Therapeutics CTMX Stock Holding History

Peregrine Asset Advisers’s Portfolio CTMX Stock Details CTMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$22.7K	Hold
2025 Q1	$6.36K	Hold
2024 Q4	$10.3K	Hold
2024 Q3	$11.8K	Buy